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Abstract
Optic nerve degeneration caused by glaucoma is a leading cause of blindness worldwide. Patients affected by the normal-
pressure form of glaucoma are more likely to harbor risk alleles for glaucoma-related optic nerve disease. We have
performed a meta-analysis of two independent genome-wide association studies for primary open angle glaucoma (POAG)
followed by a normal-pressure glaucoma (NPG, defined by intraocular pressure (IOP) less than 22 mmHg) subgroup analysis.
The single-nucleotide polymorphisms that showed the most significant associations were tested for association with a
second form of glaucoma, exfoliation-syndrome glaucoma. The overall meta-analysis of the GLAUGEN and NEIGHBOR
dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the
CDKN2BAS region on 9p21 (rs2157719 [G], OR = 0.69 [95%CI 0.63–0.75], p = 1.86610218), and the SIX1/SIX6 region on
chromosome 14q23 (rs10483727 [A], OR = 1.32 [95%CI 1.21–1.43], p = 3.87610211). In sub-group analysis two loci were
significantly associated with NPG: 9p21 containing the CDKN2BAS gene (rs2157719 [G], OR= 0.58 [95% CI 0.50–0.67],
p = 1.17610212) and a probable regulatory region on 8q22 (rs284489 [G], OR = 0.62 [95% CI 0.53–0.72], p = 8.88610210).
Both NPG loci were also nominally associated with a second type of glaucoma, exfoliation syndrome glaucoma (rs2157719
[G], OR = 0.59 [95% CI 0.41–0.87], p = 0.004 and rs284489 [G], OR = 0.76 [95% CI 0.54–1.06], p = 0.021), suggesting that these
loci might contribute more generally to optic nerve degeneration in glaucoma. Because both loci influence transforming
growth factor beta (TGF-beta) signaling, we performed a genomic pathway analysis that showed an association between
the TGF-beta pathway and NPG (permuted p= 0.009). These results suggest that neuro-protective therapies targeting TGF-
beta signaling could be effective for multiple forms of glaucoma.
Citation: Wiggs JL, Yaspan BL, Hauser MA, Kang JH, Allingham RR, et al. (2012) Common Variants at 9p21 and 8q22 Are Associated with Increased Susceptibility
to Optic Nerve Degeneration in Glaucoma. PLoS Genet 8(4): e1002654. doi:10.1371/journal.pgen.1002654
Editor: Gregory S. Barsh, Stanford University School of Medicine, United States of America
Received January 3, 2012; Accepted March 1, 2012; Published April 26, 2012
Copyright:  2012 Wiggs et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLoS Genetics | www.plosgenetics.org 1 April 2012 | Volume 8 | Issue 4 | e1002654
Funding: This work was supported by the following: Genotyping services for the NEIGHBOR study were provided by the Center for Inherited Disease Research (CIDR)
and were supported by the National Eye Institute through grant HG005259-01 (JL Wiggs). Additionally, CIDR is funded through a federal contract from the National
Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. Genotyping for the GLAUGEN dataset at the Broad Institute was
supported by GENEVA project grant HG004728 (LR Pasquale) and U01-HG004424 (Broad Institute). Genotype data cleaning and analysis for the GLAUGEN study was
supported by U01 HG004446 (C Laurie). Collecting and processing samples for the NEIGHBOR dataset was supported by the National Eye Institute through ARRA
grants 3R01EY015872-05S1 (JL Wiggs) and 3R01EY019126-02S1 (MA Hauser). Support for ENCODE was provided through grants RC1HG005334 and U54HG004570.
Funding for the collection of cases and controls was provided by NIH grants: EY015543 (RR Allingham), EY006827 (D Gaasterland); HL73042, HL073389, EY13315 (MA
Hauser); CA87969 (JH Kang), CA49449 (JH Kang), CA55075 (JH Kang), EY009149 (PR Lichter), HG004608 (C McCarty), EY008208 (FA Medeiros), EY015473 (LR Pasquale),
EY012118 (M Pericak-Vance), EY015682 (A Realini), EY011671 (JE Richards), EY09580 (JE Richards), EY013178 (JS Schuman), RR015574, EY015872 (JL Wiggs), EY010886
(JL Wiggs), EY009847 (JL Wiggs), EY011008, EY144428 (K Zhang), EY144448 (K Zhang), EY18660 (K Zhang). We also thank the staff of the Vanderbilt Computational
Genomics Core for their help in collating and analyzing these data and the University of Washington and Duke ENCODE groups for making DNase data available pre-
publication. JL Wiggs and LR Pasquale are also supported by the Harvard Glaucoma Center for Excellence and the Margolis Fund. BL Yaspan was supported in part by
NIH grant T32EY021453. Y Liu is supported by the Glaucoma Research Foundation, American Health Assistance Foundation, and the Glaucoma Foundation. JL Wiggs,
LR Pasquale, DC Musch, and JE Richards are supported by Research to Prevent Blindness. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: janey_wiggs@meei.harvard.edu
. These authors contributed equally to this work.
" These authors also contributed equally to this work.
Introduction
Glaucoma is a leading cause of blindness worldwide [1].
Primary open angle glaucoma (POAG), the most common form of
glaucoma in the Western world, is an age-related, complex disease
characterized by progressive irreversible degeneration of the optic
nerve due to apoptotic retinal ganglion cell death [2]. In addition
to age, epidemiologic studies have revealed multiple risk factors for
the condition including elevated intraocular pressure (IOP),
African-American race, family history and low ocular perfusion
pressure [3–5]. Of these, elevated intraocular pressure (IOP) is the
only treatable risk factor; however, many individuals have IOP
elevation without optic nerve disease [6], and at least 33% of
affected individuals have progressive retinal ganglion cell loss
despite IOP measurements in the normal range (less than
22 mmHg), a condition defined as normal-pressure glaucoma
(NPG) [7]. Preventative or neuro-protective therapies for glauco-
ma are not yet available and little is known about the molecular
events that influence susceptibility to glaucomatous optic nerve
degeneration.
POAG is genetically complex [8]. Linkage studies have
identified over 20 genomic regions likely to contain POAG-related
genes [9]. Importantly, genes that influence POAG risk overall
may specifically contribute to separate independent biological
processes affecting the disease outcome including regulation of
IOP and retinal ganglion cell physiology. Individuals with elevated
IOP without optic nerve disease may only carry genetic variants
that influence IOP regulation, while individuals with NPG may
primarily carry genetic variants that predispose to retinal ganglion
cell death as the nerve degenerates in these patients without the
added stress of elevated IOP.
Recent genome-wide association studies (GWAS) have identi-
fied several genetic risk factors for POAG overall, including single-
nucleotide polymorphisms (SNPs) located in the CAV1/CAV2
intergenic region [10–11], and in the genomic regions containing
the TMCO1 and CDKN2BAS genes [12] in a study of glaucoma
patients with advanced optic nerve disease. Linkage studies have
identified two genes that contribute to rare familial forms of NPG,
OPTN (optineurin) [13] and TBK1 (TANK-binding kinase) [14],
and an intronic SNP in SRBD1 (S1 RNA binding domain) has
been associated with NPG in a GWAS of 355 Japanese cases [15].
Genome-wide association studies have not yet identified genes
commonly associated with normal-pressure glaucoma or with
optic nerve disease in glaucoma. The identification of genes that
influence glaucoma-related optic nerve degeneration is an
important step toward the development of neuro-protective
therapies that could substantially reduce the morbidity caused by
this common disease, and such therapies could be relevant to optic
nerve degeneration occurring in many chronic forms of glaucoma.
To identify genes that predispose to glaucomatous optic nerve
disease, we completed two GWAS for POAG: the GLAUGEN
(Glaucoma Genes and Environment) GWAS that is part of the
GENEVA (GENEVA Genes Environment Association) studies
[16] and the NEIGHBOR (NEI Glaucoma Human genetics
collaBORation) GWAS [17]. We then performed a meta-analysis
as well as normal-pressure and high-pressure subgroup analyses of
the combined dataset. To determine if the observed associations
were specific to POAG or could generalize more broadly to optic
nerve disease in other forms of glaucoma we selected the lead
SNPs showing significant association in the normal-pressure
glaucoma subgroup analysis, and tested them for association with
glaucoma in a population of unrelated individuals with exfoliation
syndrome glaucoma.
Results
Genome-wide association studies and meta-analyses
After data cleaning, 976 cases and 1,140 controls collected from
three study sites [Nurses’ Health Study, Health Professionals
Follow-up Study and the Genetic Etiologies of Primary-Open
angle Glaucoma Study (GEP)] were analyzed for the GLAUGEN
study, and 2,170 cases and 2,347 controls collected from 12 sites
(Table S1) were analyzed for the NEIGHBOR study. All cases and
controls for both studies were residents of the continental United
States and were of mainly European ancestry, which was
confirmed by principal component analysis. The general charac-
teristics for the cases and controls are shown in Table 1. For
POAG overall in the GLAUGEN GWAS, there were no SNPs
with p-values that reached the genome-wide significance level of
p = 561028 (Figure S1 and Figure S2).
In the NEIGHBOR overall POAG GWAS, there were
seventeen SNPs that reached the genome-wide significance level
of p = 561028. Sixteen of the significant SNPs were found in the
CDKN2BAS gene region on chromosome 9p21.3 (top SNP
rs4977756 (OR=0.66 [95% CI 0.59–0.73], p value = 7.4610216).
The remaining significant SNP rs10483727 was located in the
SIX1/SIX6 region on chromosome 14 (OR=1.32 [95% CI 1.20–
1.46], p value = 3.161028). (Figure S3 and Figure S4; Table S2).
Using METAL [18], we conducted a meta-analysis of the
GLAUGEN and NEIGHBOR datasets that included a total of
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3,146 cases and 3,487 controls and found nineteen SNPs that
achieved genome-wide significance for POAG overall (Figure S5):
seventeen of them in the CDKN2BAS region, with the most
significant SNP being rs2157719 (OR=0.69 [95%CI 0.63–0.75],
p = 1.86610218, and two SNPs in the SIX1/SIX6 region on
chromosome 14q23 (most significant SNP: rs10483727,
OR=1.32 [95%CI 1.21–1.43], p = 3.87610211) (Table S3). A
number of genomic regions, including the CDKN2BAS and SIX1/
SIX6 regions have been previously associated with optic nerve
quantitative parameters (cup-to-disc ratio (CDR) and optic nerve
area) [19–24]. Of these, only the CDKN2BAS and SIX1/SIX6
regions were significantly associated with glaucoma in the meta-
analysis, although several other previously identified gene regions
demonstrated suggestive associations including SALL1, LRP1B and
SIRPA (Table 2, Table S4).
Normal-pressure and high-pressure subgroup analyses
To identify genetic risk factors primarily associated with optic
nerve disease in glaucoma, we performed separate meta-analyses
for NPG (720 cases) and high-pressure glaucoma (HPG, 1669
cases with IOP $22 mm Hg), (757 cases did not have untreated
IOP data available). In the HPG meta-analysis, no SNPs, even
those in the CDKN2BAS and SIX1/SIX6 regions, reached genome-
wide significance (Figure S6). In the NPG meta-analysis, SNPs in
two regions reached genome-wide significance, (Figure 1, Table 3):
thirteen SNPs in the CDKN2BAS region on 9p21 (most significant
SNP was rs2157719, (OR=0.58 [95% CI 0.50–0.67],
p = 1.17610212) (Figure 2, Figure S7) and three SNPs in an
evolutionarily conserved region on chromosome 8q22 (most
significant SNP was rs284489, OR=0.62 [95% CI 0.53–0.72],
p = 8.88610210) (Figure 3, Figure S8).
Single–SNP associations
Chromosome 9p21 region. After imputation 90 SNPs in the
9p21 region were significantly associated with NPG (Table S5),
although conditional analysis showed that none of these were
independent of rs2157719, the most significantly associated SNP
in the meta-analysis. The minor allele for rs2157719 showed a
protective effect, and is located within the genomic region coding
for the noncoding RNA, CDKN2BAS, also known as ANRIL,
which regulates expression of CDKN2B as well as other genes [25].
rs2157719 falls within a DNase I hypersensitivity site [26] that has
a significant signal in a variety of cell types [27] (Figure S9).
Targeted re-sequencing of the CDKN2BAS gene in a subset of 11
cases carrying a protective haplotype that includes rs2157719
(Table S6) identified two rare variants (rs7341786 [A]; rs7341791
[A]) in 8 of the 11 individuals. After imputation we found that
these variants are significantly associated with glaucoma (p=
2.7361029, OR=0.75; p= 3.0961029, OR=0.75 respectively).
These SNPs have been previously shown to affect RNA splicing
[28], suggesting that altering CDKN2BAS expression may con-
tribute to glaucoma.
Chromosome 8q22 region. The three SNPs located in the
8q22 region that were significantly associated with NPG in the
subgroup analysis are in strong linkage disequilibrium (r2.0.8)
(Figure S8), and imputation followed by conditional analysis did
not reveal additional independent associations. The genomic
region containing the associated SNPs includes highly conserved
DNA sequences and several DNaseI hypersensitivity sites [26,27]
(Figure S10). An imputed SNP (rs284492) in strong LD with the
lead SNP (rs284489) falls within or proximal to DNaseI
hypersensitivity sites with significant activity in choroid plexus
epithelial cells, as well as two ocular tissues (nonpigmented ciliary
epithelial cells, and iris pigment epithelial cells) (Figure S10, Table
Author Summary
Loss of vision from glaucoma, a common cause of blindness
worldwide, is due to irreversible damage to the optic nerve.
Current therapies cannot prevent glaucoma-related optic
nerve disease and very little is known about the underlying
responsible molecular events. Glaucoma patients affected
by the ‘‘normal-pressure’’ subtype of glaucoma (NPG) have
increased susceptibility to optic nerve degeneration.
Although NPG has a high heritability, common predisposing
genetic variants have not been identified. Therefore, we
performed a meta-analysis of two independent genome-
wide association studies for a common form of glaucoma,
primary open angle glaucoma (POAG), followed by NPG
subgroup analysis. We found that SNPs in the CDKN2BAS
gene region on 9p21 and a highly conserved region with a
probable regulatory function on 8q22 were associated with
NPG and with optic nerve disease in a second type of
glaucoma, exfoliation glaucoma. Both genomic regions are
predicted to influence TGF-beta activity, and using whole-
genome data we showed that the TGF-beta signaling
pathway overall is associated with NPG. These results reveal
new insights into the molecular pathogenesis of optic nerve
disease in glaucoma and are an important step toward the
development of preventative and protective therapies.
Table 1. Features of cases and controls.
Number Mean Age (years)* % Female
Dataset Cases Controls Cases Controls Cases Controls
GLAUGEN 976 1140 63.6 65.5 60% 58%
NEIGHBOR 2170 2347 66.4 68.0 53% 54%
Meta-analysis (all) 3146 3487 65.2 67.5 54% 57%
Meta-analysis (NPG) 720 3443 61.2 67.5 58% 57%
Meta-analysis (HPG) 1669 3487 65.3 67.6 52% 57%
GLAUGEN=Glaucoma Genes and Environment study.
NEIGHBOR=NEI Glaucoma Human genetics collaBORation study.
NPG=Normal-pressure glaucoma defined as IOP ,22 mm Hg at diagnosis.
HPG=High-pressure glaucoma defined as IOP $22 mm Hg at diagnosis.
*The mean for each group is listed.
doi:10.1371/journal.pgen.1002654.t001
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S5). Haplotypes significantly associated with NPG (Table S7)
include these DNaseI hypersensitivity sites. This putative
regulatory region is located within a 630 Kb gene desert flanked
by LRP12 (Low-density lipoprotein receptor related protein 12)
and ZFPM2 (Zinc finger protein multitype 2) and could influence
expression of either of these genes.
Table 2. Glaucoma association results for SNPs in gene regions associated with quantitative optic nerve parameters optic nerve
area and cup-to-disc ratio (CDR).
Optic nerve area
Gene region Reference SNP* P overall OR overall P HPG OR HPG P NPG OR NPG
ATOH7 19,20,21 rs17231602:A 0.049 0.89 0.322 0.93 0.903 1.01
RFTN1 19 rs12487874:A 4.80E-03 1.15 0.307 1.07 5.03E-03 1.27
CDC7/TGFBR3 20, 21, 22 rs11165816:G 2.04E-03 0.79 0.064 0.84 0.014 0.73
SALL1 20 rs3743795:G 0.320 0.95 0.487 0.95 8.54E-04 0.74
CARD10 21 rs9607468:A 0.289 0.92 0.662 0.96 8.44E-03 0.69
ELP4-PAX6 23 rs677874:C 0.749 0.98 0.872 0.99 0.0126 0.80
LRP1B 22 rs2381190:C 8.90E-04 1.17 0.024 1.15 0.507 1.06
Optic nerve morphology (Cup-to-disc ratio)
Gene region Reference SNP* P overall OR overall P HPG OR HPG P NPG OR HPG
CDKN2B 20 rs1063192:G 2.30E-17 1.43 3.21E-05 1.26 1.13E-11 1.68
SIX1/SIX6 20 rs10483727:A 3.87E-11 1.32 6.67E-07 1.31 8.66E-05 1.33
SCYL1/LTBP3 20 rs1787663:A 0.123 0.93 0.378 0.95 0.141 0.89
CHEK2 20 rs134173:A 8.84E-03 0.90 0.501 0.97 0.044 0.87
DCLK1 20 rs11839572:T 0.486 1.04 0.629 1.03 2.58E-03 1.31
SIRPA 22 rs6034909:G 0.031 0.89 6.27E-04 0.79 0.627 1.05
RNF24/PANK2 22 rs6037744:A 4.71E-03 1.12 0.027 1.13 0.081 1.13
RERE 22 rs953043:C 4.28E-03 0.88 0.033 0.88 0.117 0.89
IGFBP2 22 rs12999653:A 0.999 1.00 0.594 1.05 0.058 0.78
DCLK3 22 rs954493:A 0.124 1.08 0.492 1.05 0.026 1.21
*The SNP in the gene region with the best evidence of association, either in the overall meta-analysis or in the HPG or NPG subgroups was selected for inclusion in this
table. The effect allele is listed after the SNP number. Complete results are presented in Table S4. Abbreviations: POAG (primary open angle glaucoma); HPG (high-
pressure glaucoma); NPG (normal-pressure glaucoma); OR (odds ratio).
doi:10.1371/journal.pgen.1002654.t002
Figure 1. Genome-wide association results with normal pressure glaucoma (NPG) (IOP ,22 mm Hg) in the GLAUGEN-NEIGHBOR
meta-analysis (720 cases and 3487 controls). The red line identifies a p-value of 561028. Covariates include: (NEIGHBOR) age, gender, study site
and eigenvectors 1 and 2; (GLAUGEN) age, gender, study site, DNA extraction method, DNA specimen type and eigenvectors 1, 2 and 6.
doi:10.1371/journal.pgen.1002654.g001
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Ocular expression of chromosome 8 genes LRP12 and
ZFPM2
Using RT-PCR, we found that both LRP12 and ZFPM2 are
expressed in the human optic nerve, as well as in other ocular
tissues relevant to glaucoma (Figure S11). In mouse experiments
using laser microdissection to selectively study specific layers of the
retina, both LRP12 and ZFPM2 were expressed in the retinal
ganglion cell and inner nuclear layers (Figure S11), making them
good candidates for optic nerve susceptibility genes.
DNA sequencing of LRP12 and ZFPM2
We performed targeted resequencing of the LRP12 and ZFPM2
genes in 16 NPG patients and also analyzed the exomes of 50
POAG cases and 18 controls for DNA sequence variants in both
genes (Table S8). None of the variants identified are expected to
significantly affect gene expression or protein function.
Association of 9p21 and 8q22 SNPs with exfoliation
glaucoma
To determine if SNPs associated with NPG were associated with
optic nerve degeneration in other types of glaucoma, we examined
the association of the top SNPs in both the 9p21 and 8q22
genomic regions with optic nerve degeneration in exfoliation
glaucoma, another form of open-angle glaucoma. Exfoliation
syndrome, a condition predisposing to elevated intraocular
pressure, is associated with genetic variants in LOXL1 [29],
Table 3. Association results for genome-wide significant SNPs for the Normal Pressure Glaucoma (NPG) analyses.
Meta-analysis NEIGHBOR GLAUGEN
SNP: Minor allele Chr P OR (95% CI) MAF P OR (95% CI) MAF P OR (95% CI)
Cases Controls Cases Controls
rs2157719:G 9 1.17E-12 0.58 (0.50–0.67) 0.27 0.42 1.70E-07 0.58 (0.47–0.71) 0.31 0.42 8.98E-07 0.58 (0.46–0.72)
rs1412829:G 9 3.12E-12 0.58 (0.50–0.68) 0.27 0.42 2.86E-07 0.58 (0.47–0.71) 0.30 0.41 1.48E-06 0.58 (0.46–0.72)
rs1063192:G 9 1.13E-11 0.60 (0.51–0.69) 0.28 0.43 2.71E-07 0.59 (0.48–0.72) 0.32 0.43 5.63E-06 0.60 (0.49–0.75)
rs573687:A 9 3.07E-11 0.58 (p.50–0.68) 0.24 0.38 1.38E-06 0.59 (0.47–0.73) 0.27 0.36 3.22E-06 0.58 (0.46–0.73)
rs3217992:A 9 1.75E-10 1.60 (1.38–1.84) 0.53 0.39 4.45E-06 1.56 (1.29–1.89) 0.47 0.39 5.90E-06 1.64 (1.32–2.02)
rs4977756:G 9 2.59E-10 0.61 (0.53–0.71) 0.26 0.40 7.31E-07 0.59 (0.48–0.73) 0.29 0.39 4.86E-05 0.64 (0.51–0.79)
rs7049105:A 9 2.96E-10 0.63 (0.55–0.73) 0.37 0.52 9.45E-06 0.65 (0.53–0.78) 0.41 0.49 4.81E-06 0.61 (0.50–0.76)
rs2151280:A 9 4.28E-10 0.64 (0.55–0.74) 0.38 0.52 2.22E-05 0.66 (0.55–0.80) 0.42 0.48 2.72E-06 0.61 (0.49–0.75)
rs284489:G 8 8.88E-10 0.62 (0.53–0.72) 0.29 0.34 3.65E-05 0.64 (0.52–0.79) 0.30 0.38 3.75E-06 0.59 (0.48–0.74)
rs1412832:G 9 8.90E-10 0.59 (0.50–0.70) 0.19 0.31 1.36E-06 0.56 (0.45–0.71) 0.21 0.31 1.48E-06 0.58 (0.47–0.72)
rs10120688:C 9 1.20E-09 0.64 (0.56–0.74) 0.37 0.50 2.67E-05 0.66 (0.55–0.80) 0.41 0.50 6.92E-06 0.62 (0.50–0.76)
rs1521774:G 8 1.35E-09 0.62 (0.53–0.72) 0.29 0.33 6.6E-05 0.65 (0.52–0.80) 0.30 0.37 3.04E-06 0.58 (0.47–0.74)
rs284495:G 8 2.35E-09 0.63 (0.53–0.72) 0.29 0.34 6.74E-05 0.65 (0.53–0.80) 0.30 0.37 5.50E-06 0.60 (0.48–0.75)
Chr= chromosome; MAF=minor allele frequency; OR=odds ratio; CI = confidence interval.
doi:10.1371/journal.pgen.1002654.t003
Figure 2. Meta-analysis results for SNPs associated with normal pressure glaucoma (NPG) (IOP ,22 mmHg) located in the
CDKN2BAS region on chromosome 9p21. The most significant SNP (rs2157719, p = 1.17610212) is indicated with a solid diamond.
doi:10.1371/journal.pgen.1002654.g002
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however, these variants appear to contribute to the development of
the exfoliation syndrome and not to optic nerve disease in POAG
[30]. We found that rs2157719 in 9p21 was significantly associated
with exfoliation glaucoma (Table 4), and rs284489 in 8q22 was
also nominally associated with the same directionality of the
association observed for NPG.
TGF–beta pathway analysis
Both the 9p21 and 8q22 regions could contribute to TGF-beta
signaling. The 9p21 SNPs could effect expression of CDKN2BAS, a
noncoding RNA that influences expression of CDKN2B, a member
of the TGF-beta signaling pathway [31]. Using the SCAN
database [32], we found that the three 8q22 SNPs associated
with NPG (rs284489, rs284495 and rs1521774) influence the
expression of TSC22 (TGF-beta stimulated clone 22), which also
modulates signaling by TGF-beta [33]. Using the PARIS (Pathway
Analysis by Randomization Incorporating Structure) algorithm
[34], we found that the TGF-beta pathway (KEGG, hsa04350)
Kyoto Encyclopedia of Genes and Genomes) overall was
associated with NPG in our combined dataset (permuted
p= 0.009).
Discussion
Using two large POAG case-control datasets, we have
completed a meta-analysis for POAG followed by subgroup
analyses for NPG and HPG. We have identified two genomic
regions that are associated with NPG and showed that the lead
SNP in each region is also associated with optic nerve disease in a
second type of open-angle glaucoma (exfoliation syndrome related
glaucoma).
The first region includes the CDKN2BAS gene on chromosome
9p21, previously associated with cup-to-disc ratio (CDR) an optic
nerve quantitative parameter, as well as POAG in candidate gene
studies [20,35,36] and more recently in a GWAS using a sample of
severely affected POAG patients [12]. In this study, we show that
this gene region is associated with NPG suggesting that
CDKN2BAS contributes to optic nerve degeneration in glaucoma.
CDKN2BAS codes for an antisense RNA that regulates the
expression of CDKN2B, which is an inhibitor of cyclin-dependent
kinase 4 (CDK4), a protein kinase that has a pivotal role in cell
cycle progression [37]. The minor alleles of the NPG associated
SNPs are protective, suggesting that these SNPs, or other variants
in linkage disequilibrium with these SNPs, could influence
CDKN2BAS and CDKN2B expression with corresponding changes
in cyclin-dependent kinase activity that could result in retinal
ganglion cell apoptosis. CDKN2BAS expression can also be
influenced by interferon alpha [38]. As inflammation and
autoimmunity may be factors contributing to glaucoma patho-
genesis [39], the regulation of CDKN2BAS expression by interferon
could suggest a direct role for CDKN2BAS in glaucoma
pathogenesis. CDKN2BAS also regulates the expression of
CDKN2A, a gene previously shown to be down-regulated in other
neurodegenerative disorders, including Alzheimer’s disease, sug-
gesting that regulation of CDKN2A expression by CDKN2BAS
could also contribute to degeneration of the optic nerve in
glaucoma [40].
The second region associated with NPG in this study is an
evolutionarily conserved DNA segment on chromosome 8q22 with
predicted regulatory function. This region partially overlaps with a
POAG locus defined by a linkage study of a single large family
with low intraocular pressure (GLC1D) [41], and a second linkage
study using multiple affected families stratified by age of disease
onset [42]. The conserved region falls within a 630 Kb gene desert
flanked by the LRP12 and ZFPM2 genes. ZFPM2, also known as
FOG2, codes for a zinc finger protein that appears to contribute to
cardiovascular development, and may have a role in ocular
development [43]. ZFPM2 is expressed in the eye, and expression
was observed to increase after injury to the optic nerve [44]. The
LRP12 gene is a member of the LRP (low-lipoprotein receptor)
gene family, with several members previously implicated in
glaucoma. LRP1 is decreased in the optic neuropathy associated
with Alzheimer’s disease [45], LRP1B is associated with optic
nerve area [22], a knock-out of LRP2 causes a glaucoma-like
phenotype in zebrafish [46], LRP4 expression is increased in
response to retinal ischemia [47], and expression of LRP10 and
Figure 3. Meta-analysis results for SNPs associated with normal pressure glaucoma (NPG) (IOP ,22 mm Hg) located in the 8q22
region. The most significant SNP (rs284489, p = 8.8610210) is indicated with a solid diamond.
doi:10.1371/journal.pgen.1002654.g003
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LRP11 is up-regulated in a rat model of glaucoma [48,49].
Importantly, LRP12, previously known as ST7, is a receptor for
SMAD4, a major regulator of the TGF-beta signaling pathway
[50]. Interestingly, SMAD4 influences activity of TSC22 [51].
The 8q22 genomic region associated with NPG contains
putative regulatory sites that appear to be active in two cell types
that could contribute to glaucoma-related optic nerve disease,
choroid plexus epithelial cells and non-pigmented ciliary body
epithelial cells. The choroid plexus is responsible for formation of
cerebral spinal fluid, and recent studies have suggested that low
cerebral spinal fluid pressure, which could be caused by decreased
formation of cerebral spinal fluid, may create a deleterious
gradient across the lamina cribrosa in NPG mimicking a similar
gradient induced by higher IOP in HPG [52,53]. The 8q22
regulatory region is also active in non-pigmented ciliary body
epithelial cells, which affect ocular intraocular pressure through
the production of aqueous humor (a fluid that is similar in
composition to cerebral spinal fluid).
Both genomic regions identified in this study could contribute to
regulation of TGF-beta signaling and our pathway analysis
provides additional support for a role for TGF-beta signaling in
glaucomatous optic nerve disease and retinal ganglion cell death.
TGF-beta and other members of the TGF-beta signaling pathway
have been previously implicated in glaucoma [54,55], and genes
participating in TGF-beta signaling are expressed in ocular
structures that are involved in glaucoma, including the anatomic
structures regulating IOP and the optic nerve [56–58]. TGF-beta1
is up-regulated in optic nerve tissue in an animal model of
glaucoma [59], and mutations in LTBP2 (latent transforming
growth factor beta binding protein 2) cause a rare autosomal
recessive form of congenital glaucoma [60]. Collectively, these
results suggest that therapies directed toward the regulation of
TGF-beta signaling could protect the optic nerve from degener-
ation in glaucoma. The discovery of POAG genetic risk factors,
especially the factors that predispose to glaucoma-related optic
neuropathy, is a critical first step toward understanding the
pathophysiology of POAG and the development of gene-based
screening tests and neuro-protective therapies for this common
blinding disease.
Methods
Subjects
The institutional review boards of the Massachusetts Eye and
Ear Infirmary, Harvard School of Public Health, the Brigham and
Women’s Hospital, University of Pittsburgh, Johns Hopkins
University, Duke University, University of West Virginia,
University of Miami, University of Michigan, Stanford University,
Marshfield Clinic, and the University of California, San Diego.
approved this study.
Clinical definitions. POAG cases were defined as
individuals for whom reliable visual field (VF) tests show
characteristic VF defects consistent with glaucomatous optic
neuropathy. Individuals were classified as affected if the VF
defects were reproduced on a subsequent test or if a single
qualifying VF was accompanied by a cup-disc ratio (CDR) of 0.7
or more in at least one eye. The examination of the ocular anterior
segment did not show signs of secondary causes for elevated IOP
such as exfoliation syndrome or pigment dispersion syndrome and
the filtration structures were deemed to be open based on clinical
measures. Elevation of IOP was not a criterion for inclusion;
however, 67% of cases did have a history of elevated IOP
($22 mm Hg) measured in a clinical setting (typically between the
hours of 8AM and 5PM) and were classified as high-pressure
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glaucoma (HPG). Cases with IOP ,22 mm Hg measured in the
clinic at the time of study enrollment (without treatment) were
classified as normal-pressure glaucoma (NPG). Cases undergoing
IOP-lowering therapy at the time of enrollment were included in
the HPG group if they had a documented history of IOP .22
prior to treatment and cases undergoing IOP-lowering therapy at
the time of enrollment were included in the NPG if they did not
have recorded pressures .22 mmHg before treatment. As
glaucoma patients are long-term patients with several clinic visits
each year, for most of the glaucoma cases in this study the IOP
measurements were made at least twice on multiple occasions.
Exfoliation glaucoma cases had evidence of characteristic fibrillar
deposits as previously described [61] in addition to glaucoma as
defined above. Controls had normal optic nerves (cup-disc ratios
#0.6) and normal intraocular pressure (#21 mm Hg).
Dataset descriptions. The GLAUGEN dataset included 976
cases and 1,140 controls drawn from three different studies: the
Genetic Etiologies of Primary-Open angle Glaucoma (GEP), the
Nurses’ Health Study (NHS) and the Health Professionals Follow-
up study (HPFS). The GEP is a clinic-based case-control set, and the
NHS and HPFS are case-control sets nested within population-
based studies. Additional information about the case identification
and control selection process in GLAUGEN can be found at The
Primary Open-Angle Glaucoma Genes and Environment
(GLAUGEN) Study. Study Accession: phs000308.v1.p1. www.
ncbi.nlm.nih.gov/projects/gap. December 21, 2010. The majority
of DNA samples were prepared using Qiagen extraction kits
(Invitrogen). More than half of the samples were derived from
buccal cells, and we previously demonstrated the feasibility of
genotyping buccal cell DNA on the Illumina 660W Quad platform
[62].
Cases and controls for the NEIGHBOR study were collected
from 12 sites (Table S1). Additional information about the
NEIGHBOR consortium can be found in reference 17.
Genome-wide association studies
Genotyping and quality control. Genotyping for the
GLAUGEN and NEIGHBOR samples was completed using the
Illumina Human660W_Quad_v1 array. (Illumina, San Diego,
CA) at the Broad Institute (GLAUGEN) and the Center for
Inherited Diseases Research (CIDR) (NEIGHBOR). At both of
the genotyping centers, samples were plated to allow equal
representation of cases and controls per plate from each study site
in order to minimize batch effects.
For the GLAUGEN samples genotyping calls were generated
using Illumina’s BeadStudio, GenomeStudio and Autocall soft-
ware along with genotype cluster definitions based on study
samples. SNPs with a GenTrain score ,0.636, cluster separation
score ,0.4 and call rate ,97% were considered technical failures
at the genotyping center and were automatically deleted before
release for further quality control. Data was released for 2,241
study samples (95% of attempted samples). Subsequent data
quality control measures consisted of identifying and removing
samples with gender misidentification, unexpected duplicates and
unexpected relatedness. Analysis of connectivity removed samples
that appeared to be related to other samples and/or suggestive of
contamination. Any SNP with missing call rate .2% or with
Hardy Weinberg p-value,1024 in the control population was
excluded. Logistic regression analysis indicated that study site
(GEP, NHS or HPFS), DNA source (blood or cheek cell), and
DNA extraction method (DNAzol, Qiagen or GENTRA) were
independent predictors of genotyping call rate for the GLAUGEN
samples. Hence, these variables along with age and gender were
used in the logistic regression models.
For the NEIGHBOR samples data from CIDR was released for
5,155 study samples (97% of attempted samples). Study samples,
including 117 study duplicates, were plated and genotyped
together with 227 HapMap controls (208 CEU; 11 YRI, 4 JPT,
4 CHB). Genotyping was performed using Illumina Human660W-
Quadv1_C BeadChips (Illumina, San Diego, CA, USA) and the
Illumina Infinium II assay protocol [63]. Allele cluster definitions
for each SNP were determined using Illumina GenomeStudio
Genotyping Module version 1.7.4, GenTrain version 1.0 and the
combined intensity data from 99.9% of the samples. The resulting
cluster definitions were used on all samples. Genotypes were not
called if the quality threshold (Gencall score) was below 0.15.
Genotypes were released by CIDR for 557,029 SNPs (99.58% of
attempted). Genotypes were not released for SNPs that had call
rates less than 85%, more than 1 HapMap replicate error, cluster
separation less than 0.2, more than a 3% (autosomal) or 2.2% (X
chromosome) difference in call rate between genders, more than
0.4% (X chromosome) male heterozygosity, or more than a 8%
(autosomal) difference in AB frequency. XY, Y and mitochondrial
SNPs were manually reviewed and clusters adjusted or genotypes
dropped as appropriate. Intensity data was released for all
attempted SNPs. The mean non-Y SNP call rate and mean
sample call rate was 99.9% for the released CIDR dataset. Study
duplicate reproducibility was 99.99%. After applying quality
control filters, 495,132 SNPs were analyzed in 976 cases and 1140
controls for GLAUGEN and 523,528 SNPs were analyzed in 2170
cases and 2347 controls for NEIGHBOR.
Association analysis. Logistic regression to assess the
association between individual SNPs and POAG was done using
PLINK v1.07 [64]. For GLAUGEN, the logistic regression model
included age, gender, study site, DNA source, DNA extraction
method and 3 eigenvectors (EV 1, 2 and 6). For NEIGHBOR, the
logistic regression model included age, gender, study site and 2
eigenvectors (EV1 and 2). Quantile-quantile plots (Figures S1 and
S3) were used to estimate genomic inflation factors which were
1.009 for GLAUGEN and 1.034 for NEIGHBOR.
Meta-analysis
Combined meta-analysis of the GLAUGEN and NEIGHBOR
datasets was done using the METAL [18] software package. We
analyzed each study using logistic regression as described
previously. Then, we combined the results using the inverse
weighted variance method based on the regression coefficients and
standard errors estimated from each study as implemented in the
program METAL [18]. The GENOMICCONTROL option was
set to ON to adjust for genomic inflation differences between the
studies.
Haplotype analysis
Haplotype analysis (logistic regression) was performed with
PLINK 1.07 [64] using sliding windows of 2–6 SNPs across the
associated regions. Covariates in the model were the same as for
the single-allele analyses.
Pathway analysis
Pathway analysis was done using the Pathway Analysis by
Randomization Incorporating Structure (PARIS) pathway analysis
software package [34]. Genes comprising the transforming growth
factor beta (TGF-beta) pathway were identified using the KEGG
database (hsa:04350). SNPs were considered to reside in a pathway
gene if the SNP fell within the ENSEMBLE genomic interval+/
250 kb to either side of the gene. If the overlap included another
gene, the overlapping SNP(s) were counted once. A single-allele p-
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value of ,0.05 was considered to be nominally significant and
included in the PARIS analysis.
Imputation
Focused regional imputation was used to infer genotypes for
SNPs not directly genotyped using MACH 1.0 [65,66] to impute
to the 1000 genomes data, release 2010–06. SNPs with a quality
score (Rsq) of ,0.5 were discarded before analysis. The resulting
genotypes were analyzed using PLINK with the same covariates
for each dataset as the non-imputed analyses. The meta-analysis
procedure was also identical to that described above.
Ocular expression study of LRP12 and ZFPM2 in an animal
model
Mouse laser capture microdissection. Retinas from adult
mice were isolated, processed, and subjected to laser capture
microdissection. cDNA purified from the respective cell layers was
synthesized and analyzed by quantitative PCR as previously
described [67].
Human ocular expression. Total RNA was extracted from
dissected tissues (cornea, trabecular meshwork, retina, optic nerve)
from normal human donor eyes as previously described [68].
Primer sequences were designed to specifically amplify the LRP12
and ZFPM2 genes. Amplification products were visualized by gel
electrophoresis.
DNA sequencing
Targeted resequencing using Sanger methods as described [69]
was carried out on genes from the associated loci on chromosome
8 and chromosome 9. All exons of LRP12 and ZFPM2 were
sequenced in 16 NPG patients, and all exons of CDKN2BAS were
sequenced in 11 cases carrying a protective haplotype including
rs2157719 (Table S6). Genomic DNA was sequenced using
primers designed to amplify the coding exons as well as the
adjacent splice sites for both genes. PCR products were directly
sequenced on the ABI PRISM 3100 Genetic Analyzer (Applied
Biosystems) with BigDye Terminators (Applied Biosystems)
according to standard protocols. Methods and analysis for exome
sequencing are described in Text S1.
Association with exfoliation glaucoma
Exfoliation cases were collected from the Massachusetts Eye and
Ear infirmary glaucoma clinic (cases) and the comprehensive eye
service (controls in GLAUGEN or NEIGHBOR). All cases and
controls were examined by a board certified ophthalmologist prior
to study enrollment. The lead SNPs for each region associated
with NPG were analyzed in 196 Caucasian patients with
exfoliation syndrome, 104 of who also had glaucoma as defined
as above. Single-SNP associations were analyzed using chi-square
and logistic regression models adjusting for age.
Web resources
PLINK (http://pngu.mgh.harvard.edu/,purcell/plink/); EI-
GENSOFT (http://genepath.med.harvard.edu/,reich/Software.
htm); ENCODE (http://genome.ucsc.edu/ENCODE/); SCAN
(http://www.scandb.org/newinterface/about.html); KEGG (http://
www.genome.jp/kegg/); UCSC genome (http://genome.ucsc.edu/);
ENSEMBL (http://useast.ensembl.org/index.html).
Supporting Information
Figure S1 GLAUGEN QQ Plot. Quantile-quantile plots of P-
values from using the logistic regression model that includes sex,
age, study site (Nurses’ Health Study, Health Professionals Follow-
up Study and Genetic Etiology Primary Open-Angle Glaucoma),
DNA source (blood or buccal), extraction method (DNAzol,
Gentra or Qiagen), Eigen vectors 1, 2, and 6 as covariates.
(TIF)
Figure S2 GLAUGEN genome-wide associations with primary
open-angle glaucoma (POAG). Results of the logistic regression
case control analysis for the GLAUGEN dataset (976 cases and
1183 controls). The blue line represents a p-value of 161024. SNP
chromosome location is on the X axis and the p-value (2log10(p))
on the y axis. The logistic regression model includes sex, age, study
site (Nurses’ Health Study, Health Professionals Follow-up Study
and Genetic Etiology Primary Open-Angle Glaucoma), DNA
source (blood or buccal), extraction method (DNAzol, Gentra or
Qiagen), Eigenvector (EV) 1, EV2, and EV6 as covariates.
(TIF)
Figure S3 NEIGHBOR QQ Plot. Quantile-quantile plots of p-
values from using the logistic regression model that includes sex,
age, study site (See Table S1), Eigenvector (EV)1, and EV2 as
covariates.
(TIF)
Figure S4 NEIGHBOR genome-wide associations with primary
open-angle glaucoma (POAG). Results of the logistic regression
case control analysis for the NEIGHBOR dataset (2,517 cases and
2,428 controls). The red line identifies a p-value of 561028. The
logistic regression model includes sex, age, study site (See Table
S1), Eigenvector (EV)1, and EV2 as covariates.
(TIF)
Figure S5 Genome-wide association results with primary open-
angle glaucoma for the GLAUGEN-NEIGHBOR meta-analysis.
The red line identifies a p value of 561028. SNP chromosome
location is on the X axis and the p-value (2log10(p)) on the y axis.
Covariates include: (NEIGHBOR) age, gender, study site and
eigenvectors 1 and 2; (GLAUGEN) age, gender, study site, DNA
extraction method, DNA specimen type and eigenvectors 1, 2 and
6.
(TIF)
Figure S6 Genome-wide association results for High Pressure
Glaucoma (HPG) in the GLAUGEN-NEIGHBOR meta-analysis.
Results of the high-tension glaucoma (HTG) (IOP .22 mm Hg at
or before diagnosis) meta-analysis (1669 cases and 3487 controls).
The blue line identifies a p-value of 161024. Covariates include:
(NEIGHBOR) age, gender, study site and eigenvectors 1 and 2;
(GLAUGEN) age, gender, study site, DNA extraction method,
DNA specimen type and eigenvectors 1, 2 and 6.
(TIF)
Figure S7 9p21 genomic region associated with NPG. Depicted
are predicted genes and splice variants for CDKN2BAS, CDKN2B
and CDKN2A as seen in the UCSC Genome browser. Genotyped
SNPs passing quality control measures that were not nominally
significant in the NPG case-control analysis are colored black.
SNPs that were nominally significant are colored blue
(0.05,p,161024), orange (161024,p,561028) and red
(p,561028).
(TIF)
Figure S8 8q22 genomic region associated with NPG. Depicted
are predicted genes and splice variants for the 8q22 region as seen
in the UCSC Genome browser. Genotyped SNPs passing quality
control measures that were not nominally significant in association
with normal pressure glaucoma in the case-control analysis are
colored black. SNPs that were nominally significant are colored
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blue (0.05,p,161024), orange (161024,p,561028) and red
(p,561028).
(TIF)
Figure S9 DNaseI signals for various cell types in a portion of
the chromosome 9p21 region associated with NPG. The location
of the lead SNP in this region rs2157719 is highlighted. Of the 120
cell types considered the lead SNP overlaps DNaseI sites in six of
them. Two signal tracks for each cell line are presented.
Vertebrate sequence homology, a chromatin state segmentation
where orange indicates candidate strong enhancers, and GERP
(Genomic Evolutionary Rate Profiling) scores are shown below the
SNP locations. Abbreviations: HBMEC, brain microvascular
endothelial cells; HEEpiC, esophageal epithelial cells; HMEC,
mammary epithelial cells; LNCaP, prostate cancer cells; NHEK,
epidermal keratinocytes; SAEC, small airway epithelial cells; WI-
38 embryonic lung fibroblast cells; HPDE6, pancreatic duct cells.
(TIF)
Figure S10 DNaseI signals for various cell types in the
chromosome 8q22 region associated with NPG. Of the 120 cell
types tested, one SNP, rs284492, in strong LD (r2.0.8) with the
lead SNP, rs284489, overlapped a DNaseI site. The figure shows
the 10 cell types with DNaseI sites overlapping or proximal to
rs284492. Two signals for each cell line are presented. Vertebrate
sequence homology, the locations of the DNaseI hypersensitivity
sites and GERP (Genomic Evolutionary Rate Profiling) scores are
shown below the SNP locations. Abbreviations: HAc, astrocytes-
cerebellar; HA-h, astrocytes-hippocampal; HA-sp, astrocytes
spinal cord; HBMEC, brain microvascular endothelial cells;
HCPEpiC, choroid plexus epithelial cells; HIPEpiC, iris pigment
epithelial cells; HNPCEpiC, non-pigment ciliary epithelial cells;
NH-A astrocytes; NHLF, lung fibroblasts; WERI-RB-1 retino-
blastoma.
(TIF)
Figure S11 Ocular expression studies for LRP12 and ZFPM2.
Ocular expression studies for LRP12 and ZFPM2. Panel A, Ocular
expression in tissues dissected from two human cadaver eyes.
Panel B. Quantitative PCR results from laser microdissection in
mouse retina. The y-axis is the abundance of the mRNA relative
to Gapdh for each cell layer. Each bar represents the average of 3
(GCL, INL) and 4 (ONL) independent adult mouse samples.
Abbreviations: Cor, cornea; Tm, trabecular meshwork; On, optic
nerve; Ret, retina; GCL, ganglion cell layer; INL, inner nuclear
layer; ONL, outer nuclear layer.
(TIF)
Table S1 Sites contributing cases and controls to the NEIGH-
BOR GWAS. Cases and controls were recruited from ophthalmol-
ogy clinics (West Virginia University, University of Pittsburgh,
Johns Hopkins Medical School, Stanford University, University of
California, San Diego, University of Miami, Duke University,
University of Michigan, the Marshfield Clinic) and were examined
by ophthalmologists, using case and control definitions that were
harmonized with the GLAUGEN study. Cases and controls were
also drawn from two clinical trial populations: Advanced Glaucoma
Intervention Study (AGIS, NEI U10EY006827, D. Gaasterland PI)
and the Collaborative Initial Glaucoma Treatment Study (CIGTS,
NEI U10 EY009149, P. Lichter PI). An additional set of 1496
controls, individuals who had been examined at the Duke Eye
Center, were selected from among 7500 subjects who had
undergone cardiac catheterization at Duke Medical Center and
who are part of the CATHGEN biorepository at Duke with blood
samples collected at the time of catheterization.
(DOCX)
Table S2 Association results for genome-wide significant SNPs
(p,561028) associated with POAG for the NEIGHBOR
GWAS. Chr= chromosome, BP= genomic position in basepair,
MAF=minor allele frequency, OR=odds ratio, L95/U95= 95%
confidence interval lower and upper limits.
(DOCX)
Table S3 Association results for genome-wide significant SNPs
(p,561028) associated with POAG for the GLAUGEN
NEIGHBOR meta-analysis. Chr = chromosome, BP= genomic
position in basepair, MAF=minor allele frequency, OR=odds
ratio, L95/U95= 95% confidence interval lower and upper limits.
(DOCX)
Table S4 Association results from the NEIGHBOR-GLAU-
GEN meta-analysis for SNPs located in genomic regions
previously associated with optic nerve parameters. Alleles 1 and
2 are listed alphabetically. P values and OR (odds ratio) are listed
for POAG (primary open angle glaucoma) overall as well as for
HPG (high pressure glaucoma) and NPG (normal pressure
glaucoma). The effect allele is the minor allele. The direction
column refers to the direction of effect in the individual
GLAUGEN and NEIGHBOR datasets. The GLAUGEN direc-
tion is listed first and the NEIGHBOR direction is listed second. A
minus sign signifies an OR less than one while a plus sign indicates
an OR greater than one.
(XLSX)
Table S5 SNPs associated with NPG (p,561028) in the 9p21
and 8q22 regions after imputation. Alleles 1 and 2 are listed
alphabetically. P values and OR (odds ratio) are listed for and
NPG (normal pressure glaucoma) after imputation for the
GLAUGEN-NEIGHBOR meta-analysis. The effect allele is the
minor allele. The direction column refers to the direction of effect
in the individual GLAUGEN and NEIGHBOR datasets. The
GLAUGEN direction is listed first and the NEIGHBOR direction
is listed second. A minus sign signifies an OR less than one while a
plus sign indicates an OR greater than one.
(DOCX)
Table S6 CDKN2BAS haplotypes for the NEIGHBOR and
GLAUGEN NPG datasets. Haplotype analysis of SNPs that were
nominally significant in the CDKN2BAS regions in the NEIGH-
BOR and GLAUGEN NPG datasets. The haplotype with the
most significant association is indicated in bold text. Abbreviations:
Bp (base pair); Freq (frequency); NPG (normal pressure glaucoma);
OR (odds ratio).
(DOCX)
Table S7 Haplotypes for 8q22 associated region for the
NEIGHBOR and GLAUGEN NPG datasets. Haplotype analysis
of SNPs that were nominally significant in the 8q22 region in the
NEIGHBOR and GLAUGEN NPG datasets. Abbreviations: Bp,
base pair; Freq, frequency; NPG, normal pressure glaucoma; OR,
odds ratio.
(DOCX)
Table S8 DNA sequence variants in LRP12 and ZFPM2 in
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